Literature DB >> 16264167

When (not) to stop a clinical trial for benefit.

Stuart J Pocock.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2005        PMID: 16264167     DOI: 10.1001/jama.294.17.2228

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  33 in total

1.  Monitoring in clinical trials: benefit or bias?

Authors:  Cecilia Nardini
Journal:  Theor Med Bioeth       Date:  2013-08

2.  A public health perspective on research ethics.

Authors:  D R Buchanan; F G Miller
Journal:  J Med Ethics       Date:  2006-12       Impact factor: 2.903

Review 3.  Basic statistical considerations for physiology: The journal Temperature toolbox.

Authors:  Aaron R Caldwell; Samuel N Cheuvront
Journal:  Temperature (Austin)       Date:  2019-06-25

4.  Design of the RINSE trial: the rapid infusion of cold normal saline by paramedics during CPR.

Authors:  Conor Deasy; Stephen Bernard; Peter Cameron; Ian Jacobs; Karen Smith; Cindy Hein; Hugh Grantham; Judith Finn
Journal:  BMC Emerg Med       Date:  2011-10-13

5.  Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Authors:  David R Boulware; David B Meya; Conrad Muzoora; Melissa A Rolfes; Katherine Huppler Hullsiek; Abdu Musubire; Kabanda Taseera; Henry W Nabeta; Charlotte Schutz; Darlisha A Williams; Radha Rajasingham; Joshua Rhein; Friedrich Thienemann; Melanie W Lo; Kirsten Nielsen; Tracy L Bergemann; Andrew Kambugu; Yukari C Manabe; Edward N Janoff; Paul R Bohjanen; Graeme Meintjes
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

6.  Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.

Authors:  Richard S Schottenfeld; Marek C Chawarski; Mahmud Mazlan
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

7.  When should potentially false research findings be considered acceptable?

Authors:  Benjamin Djulbegovic; Iztok Hozo
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

8.  Trials stopped early for benefit? Not so fast!

Authors:  Alan C Heffner; Eric B Milbrandt; Ramesh Venkataraman
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).

Authors:  Matthias Briel; Melanie Lane; Victor M Montori; Dirk Bassler; Paul Glasziou; German Malaga; Elie A Akl; Ignacio Ferreira-Gonzalez; Pablo Alonso-Coello; Gerard Urrutia; Regina Kunz; Carolina Ruiz Culebro; Suzana Alves da Silva; David N Flynn; Mohamed B Elamin; Brigitte Strahm; M Hassan Murad; Benjamin Djulbegovic; Neill K J Adhikari; Edward J Mills; Femida Gwadry-Sridhar; Haresh Kirpalani; Heloisa P Soares; Nisrin O Abu Elnour; John J You; Paul J Karanicolas; Heiner C Bucher; Julianna F Lampropulos; Alain J Nordmann; Karen E A Burns; Sohail M Mulla; Heike Raatz; Amit Sood; Jagdeep Kaur; Clare R Bankhead; Rebecca J Mullan; Kara A Nerenberg; Per Olav Vandvik; Fernando Coto-Yglesias; Holger Schünemann; Fabio Tuche; Pedro Paulo M Chrispim; Deborah J Cook; Kristina Lutz; Christine M Ribic; Noah Vale; Patricia J Erwin; Rafael Perera; Qi Zhou; Diane Heels-Ansdell; Tim Ramsay; Stephen D Walter; Gordon H Guyatt
Journal:  Trials       Date:  2009-07-06       Impact factor: 2.279

10.  Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock.

Authors:  Simon Finfer; V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Bengt Gårdlund; John C Marshall; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2008-10-07       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.